- Atara Biotherapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Atara Biotherapeutics Inc Earnings Call TranscriptNov 01, 2023€1.18 (-4.34%)Earnings
- Atara Biotherapeutics Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Atara Biotherapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Atara Biotherapeutics Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Atara Biotherapeutics Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Atara Biotherapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Atara Biotherapeutics Inc Earnings Call TranscriptNov 08, 2022€4.73 (+1.76%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 Atara Biotherapeutics Inc Earnings Call TranscriptAug 08, 2022€3.43 (+2.32%)Earnings
- Atara Biotherapeutics Inc To Announce Completion of ATA188 Phase 2 EMBOLD Study TranscriptJul 12, 2022
- Q1 2022 Atara Biotherapeutics Inc Earnings Call TranscriptMay 05, 2022€6.84 (+4.01%)Earnings
- Atara Biotherapeutics Inc EBV and MS Day TranscriptMar 22, 2022
- Q4 2021 Atara Biotherapeutics Inc Earnings Call TranscriptFeb 28, 2022€11.28 (-2.76%)Earnings
- Atara Biotherapeutics Inc T-Cell Operations and Manufacturing (ATOM) Facility Acquisition by FUJIFILM Diosynth Biotechnologies (FDB) TranscriptJan 27, 2022
- Atara Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Atara Biotherapeutics Inc Earnings Call TranscriptNov 04, 2021€15.06 (+2.52%)Earnings
- Atara Biotherapeutics Inc to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021 TranscriptOct 13, 2021
- Atara Biotherapeutics Inc and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel Corporate Call TranscriptOct 04, 2021
- Atara Biotherapeutics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Atara Biotherapeutics Inc Earnings Call TranscriptAug 09, 2021€10.9 (+1.82%)Earnings
- Atara Biotherapeutics Inc at Cowen Virtual Oncology Innovation Summit TranscriptMay 20, 2021
- Q1 2021 Atara Biotherapeutics Inc Earnings Call TranscriptMay 04, 2021€11.27 (-3.18%)Earnings
- Q4 2020 Atara Biotherapeutics Inc Earnings Call TranscriptMar 01, 2021€13.84 (-1.84%)Earnings
- Atara Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Atara Biotherapeutics Inc Provides Regulatory Update for Tab-Cel® for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease TranscriptJan 04, 2021
- Atara Biotherapeutics, Inc. - Special Call TranscriptDec 07, 2020
- Atara Biotherapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Q3 2020 Atara Biotherapeutics Inc Earnings Call TranscriptNov 09, 2020€11.29 (-1.05%)Earnings
- Atara Biotherapeutics, Inc. - Special Call TranscriptSep 11, 2020
- Q2 2020 Atara Biotherapeutics Inc Earnings Call TranscriptAug 05, 2020€10.41 (-7.31%)Earnings
- Atara Biotherapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Atara Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Atara Biotherapeutics, Inc. - Special Call TranscriptMay 26, 2020
- Q1 2020 Atara Biotherapeutics Inc Earnings Call TranscriptMay 06, 2020€8.28 (+4.31%)Earnings
- Atara Biotherapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Atara Biotherapeutics Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Atara Biotherapeutics Inc Earnings Call TranscriptFeb 27, 2020€9.97 (-4.78%)Earnings
- Atara Biotherapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Atara Biotherapeutics Inc Earnings Call TranscriptNov 07, 2019€10.84 (-1.50%)Earnings
- Atara Biotherapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa TranscriptOct 02, 2019
- Atara Biotherapeutics Inc ECTRIMS Conference Call TranscriptSep 13, 2019
- Atara Biotherapeutics Inc at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 Atara Biotherapeutics Inc Earnings Call TranscriptAug 08, 2019€11.06 (+2.83%)Earnings
- Atara Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2019
- Atara Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 05, 2019
- Q1 2019 Atara Biotherapeutics Inc Earnings Call TranscriptMay 09, 2019€29.95 (-2.06%)Earnings
- Atara Biotherapeutics Inc at Cowen Health Care Conference TranscriptMar 12, 2019
Atara Biotherapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Great. Good afternoon, everyone. Thanks for joining us. I'm Salveen Richter. I cover biotechnology at Goldman Sachs, and we're really pleased to have the Atara team here with us. We have Pascal Touchon, President and CEO; and Cokey Nguyen, CSO.
Questions & Answers
So with that, Pascal, maybe you could just provide a brief overview of the company and kind of where everything stands at this point between commercialization efforts and the pipeline efforts and where we should be thinking about launch aspects or understanding the launch aspects as well as the data sets that are coming over the next year or so.
Thank you, Salveen, for your question. I mean Atara is really the leading company in the field of allogeneic T-cell therapy. And we can say that because we are the first and so far
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)